Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersInfectious Disease Physician in Boston, MA
NPI: 1407828098Primary Practice Location
BRIGHAM AND WOMEN'S HOSPITAL
75 Francis St, Boston, MA
Primary Employer
Brigham & Womens Physicians Organization Inc
brighamandwomens.org
HQ Phone
Get MDCM Stephen's Phone Numberphone_androidMobile
Get MDCM Stephen's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99223Initial hospital inpatient care, typically 70 minutes per day | 51 | 52 |
| 2 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 49 | 85 |
| 3 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 41 | 62 |
Authors: Diallo, Ana F, McGlothen-Bell, Kelly, Lucas, Ruth, Walsh, Stephen, Allen, Carolyn, Henderson, Wendy A, Cong, Xiaomei, McGrath, Jacqueline
Journal: Public Health Nurs
Publication Date: 2019-11-10
SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses.
Authors: Laura Porterfield, Anne Luetkemeyer, Ann Falsey, Richard Novak, Patricia Winokur, Dahlene Fusco, Angelica Kottkamp, Edward Walsh, Thomas Martin, John Beigel, Richard Rupp, Siham Mahgoub, Benjamin Ladner, Anna Wald, Michael Smith, Robert Atmar, David Diemert, Rachel Presti, Jennifer Whitaker, Christina Rostad
Lead Sponsor: Worcester HIV Vaccine
Collaborators: Brigham and Women's Hospital, Access to Advanced Health Institute (AAHI)
Intervention / Treatment: BIOLOGICAL: Placebo, BIOLOGICAL: env (A,B,C,A/E)/gag (C) DNA Vaccine, BIOLOGICAL: gp120 (A,B,C,A/E) Protein Vaccine, BIOLOGICAL: GLA-SE adjuvant
Lead Sponsor: Kathryn Stephenson
Collaborators: National Institute of Allergy and Infectious Diseases (NIAID), Walter Reed Army Institute of Research (WRAIR)
Intervention / Treatment: OTHER: Placebo, BIOLOGICAL: Zika Virus Purified Inactivated Vaccine
Lead Sponsor: Scynexis, Inc.
Intervention / Treatment: DRUG: Ibrexafungerp
Journal: medRxiv
Publication Date: 2022-07-15